drugset
drugset / Trial / NCT04669821

A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation

NCT04669821 ↗

Phase 2 Completed 20 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multi-center, randomized, open-label, propofol-controlled exploratory clinical study. In this study, 20 ICU patients undergoing mechanical ventilation are expected to be enrolled and will be randomly assigned to the HSK3486 group and the propofol group in a 1:1 ratio. This study is not blinded as it is open-label.

Timeline

Start
2021-03-09
Primary completion
2021-08-28
Completion
2021-10-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.3 mg/kg Intravenous
Comparator Propofol Small molecule 1.5 mg/kg —

Indications

No indication recorded.